TICKERNOMICS Sign up
Last Update: 2024-12-27 15:29:35
APPLIED DNA SCIENCES INC ( APDN ) https://www.adnas.com
0.18USD
Sector:
Healthcare
Industry:
Diagnostics & Research
Country:
United States
1y
3y
5y
10y
Historical Returns*:
SPY
27.80%
-98.60%
APDN
SPY
32.66%
-99.79%
APDN
SPY
108.59%
-99.79%
APDN
SPY
302.52%
-99.99%
APDN
*Assumes dividends reinvested
Market Stats:
Market Capitalization($MM)
Enterprise Value($MM)
Daily Volume(MM)
0.71
-8.65
2.44
Valuation Metrics:
Price/Earnings Ratio
Price/Sales Ratio
Price/Book Value
FCF Yield(%)
Dividend Yield(%)
EV/EBITDA
-0.10
0.21
0.08
-348.25
0.00
0.66
Profitability Stats:
Operating Margin %(ttm)
Gross Profit %(ttm)
EBITDA Margin %(ttm)
-402.32
30.12
-388.64
Shareholder Value Creation:
Cost of Capital %(est)
ROIC %(ttm)
ROCE %(ttm)
Beta
11.6432
-114.24
-115.47
1.99
Other Earnings and Cash Flow Stats:
APPLIED DNA SCIENCES INC ( APDN ) Net Income TTM ($MM) is -6.99
APPLIED DNA SCIENCES INC ( APDN ) Operating Income TTM ($MM) is -14.02
APPLIED DNA SCIENCES INC ( APDN ) Owners' Earnings Annual ($MM) is -14.05
APPLIED DNA SCIENCES INC ( APDN ) Current Price to Owners' Earnings ratio is -0.29
APPLIED DNA SCIENCES INC ( APDN ) EBITDA TTM ($MM) is -13.33
APPLIED DNA SCIENCES INC ( APDN ) EBITDA Margin is -388.64%
Capital Allocation:
APPLIED DNA SCIENCES INC ( APDN ) has paid 0.00 dividends per share and bought back -3.312255 million shares in the past 12 months
APPLIED DNA SCIENCES INC ( APDN ) has reduced its debt by 0.498599 million USD in the last 12 months
Capital Structure:
APPLIED DNA SCIENCES INC ( APDN ) Interest-bearing Debt ($MM) as of last quarter is 0
APPLIED DNA SCIENCES INC ( APDN ) Annual Working Capital Investments ($MM) are 0
APPLIED DNA SCIENCES INC ( APDN ) Book Value ($MM) as of last quarter is 8
APPLIED DNA SCIENCES INC ( APDN ) Debt/Capital as of last quarter is 8%
Other Balance Sheet Stats:
APPLIED DNA SCIENCES INC ( APDN ) has 10 million in cash on hand as of last quarter
APPLIED DNA SCIENCES INC ( APDN ) has 2 million of liabilities due within 12 months, and long term debt 0 as of last quarter
APPLIED DNA SCIENCES INC ( APDN ) has 3 common shares outstanding as of last quarter
APPLIED DNA SCIENCES INC ( APDN ) has 0 million USD of preferred stock value
Academic Scores:
APPLIED DNA SCIENCES INC ( APDN ) Altman Z-Score is -36.48 as of last quarter
APPLIED DNA SCIENCES INC ( APDN ) Piotroski Score is 3.00 as of last quarter
Corporate Governance:
APPLIED DNA SCIENCES INC ( APDN ) largest shareholder is Citigroup Inc owning 1841 shares at 0.00 ($MM) value
Ferguson Elizabeth M.(an insider) Bought 9948 shares of APPLIED DNA SCIENCES INC ( APDN ) for the amount of $0.00 on 2021-11-01
20.98% of APPLIED DNA SCIENCES INC ( APDN ) is held by insiders, and 25.01% is held by institutions
APPLIED DNA SCIENCES INC ( APDN ) went public on 2003-07-15
Other APPLIED DNA SCIENCES INC ( APDN ) financial metrics:
FCF:-14.24
Unlevered Free Cash Flow:-13.62
EPS:-3.32
Operating Margin:-402.32
Gross Profit Margin:30.12
Div. Payout Ratio%:0.00
Div. Growth YoY%:0.00
Equity Return%:-144.24
Beta:1.99
Buffet's Owners Earnings:-14.05
Price to Owner's Earnings:-0.29
About APPLIED DNA SCIENCES INC ( APDN ) :
Applied DNA Sciences, Inc., a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. The company operates through three segments: Therapeutic DNA Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services. The Therapeutic DNA Production Services segment develops and commercializes the LinearDNA platform, which enables a cell-free manufacture of high-fidelity synthetic DNA sequences for use in nucleic acid-based therapeutics. The MDx Testing Services segment provides clinical molecular diagnostics (MDx) testing and clinical laboratory testing services; COVID-19 testing services, including test scheduling, sample collection, and automated results reporting for higher education institutions, private clients, and businesses under the safeCircle trademark; polymerase chain reaction (PCR)-based MDx testing services for the Monkeypox virus; and MDx test kits and related supplies, as well as validates pharmacogenetics (PGx) testing services. The DNA Tagging and Security Products and Services segment offers SigNature Molecular Tags, which provides a methodology to authenticate goods within large and complex supply chains for materials, such as cotton, leather, pharmaceuticals, nutraceuticals, and other products; SigNify IF portable DNA readers and SigNify consumable reagent test kits, which offers a front-line solution for supply chain integrity backed with forensic-level molecular tag authentication; and fiberTyping, which uses PCR-based DNA detection to detect a product's naturally occurring DNA sequences for the purposes of product provenance authentication and supply chain security. The company was formerly known as Datalink Systems, Inc. and changed its name to Applied DNA Sciences, Inc. in 2002. Applied DNA Sciences, Inc. was founded in 1983 and is headquartered in Stony Brook, New York.
User Content from Tickernomics. Created by Luminus.
DISCLAIMER

This web site and its creators are not certified financial advisors. All opinions/suggestions expressed on this website should not be treated as specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion.The Company doesn't warrant the information provided on the website for its completeness or accuracy, and it should not be relied upon as such. The Company is not under any obligation to update or correct any information provided on this website.The content of this website is published in the United States of America and persons who access it agree to do so in accordance with applicable U.S. law.Past performance is not indicative of future results. The Company doesn't guarantee any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment discussed on this website.Strategies or investments discussed may fluctuate in price or value. Investors may get back less than invested. Investments or strategies mentioned on this website may not be suitable for you. This material does not take into account your particular investment objectives,financial situation or needs and is not intended as recommendations appropriate for you. You must make an independent decision regarding investments or strategies mentioned on this website. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.